Printer Friendly

ATP POSTS FIGURES FOR FIRST SIX MONTHS

 ATP POSTS FIGURES FOR FIRST SIX MONTHS
 SAN ANTONIO, Texas, Feb. 18 /PRNewswire/ -- Advanced Therapeutic


Products, Inc. (NASDAQ: ATPI) today announced revenues of $65,523 for the six-month period ended Dec. 31, 1991, and a net loss of $28,623 for the period compared to a net loss of $59,562 on revenues of $149,476 for the six-month

period ended Dec. 31, 1990. ATP has 8 million shares of common stock outstanding.
 Jim Linehan, ATP president, indicated that the company expects to receive minimum royalty payments from Kabi-Pharmacia AB aggregating $400,000 during its fiscal fourth quarter ending June 30, 1992.
 "If these optional payments are made, as expected, and pro-rated over the current fiscal year, ATP would have had earnings of $142,321, or approximately $.02 per share, for the six-month period ended Dec. 31, 1991," Linehan said.
 In 1987, ATP sold the nicotine technology it had developed to a predecessor of Kabi-Pharmacia Therapeutics AB, a Swedish, world-wide marketer of pharmaceutical products, including a nicotine smoking cessation product, the Nicorette chewing gum. In exchange for its technology, ATP obtained the right to receive payments based upon the sales by Kabi-Pharmacia of a nicotine inhaler now undergoing clinical trials.
 "We understand that, during 1992, Kabi-Pharmacia will decide whether to make a new drug application with the United States Food & Drug Administration," Linehan said. "In the event the nicotine inhaler becomes a successful commerical product, ATP can expect substantial royalty revenues from Kabi-Pharmacia."
 In response to NASDAQ's newly adopted financial maintenance standards, which ATP currently does not meet, Linehan noted that ATP is in the process of reviewing several options, including a reverse stock split.
 ATP is currently listed on NASDAQ under the symbol, ATPI.
 -0- 2/18/92
 /CONTACT: Jim Linehan of Advanced Therapeutic Products, 800-627-7142, or Cary Corbin, Dublin-McCarter & Associates, 512-227-0221, for Advanced Therapeutic Products/ CO: Advanced Therapeutic Products, Inc. ST: Texas IN: HEA SU: ERN


KD -- NY107 -- 0138 02/18/92 16:53 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 18, 1992
Words:327
Previous Article:FLORIDA REGIONAL STOCK REPORT FOR TUESDAY, FEB. 18
Next Article:VISUAL INDUSTRIES REPORTS RESULTS
Topics:


Related Articles
ATP POSTS QUARTERLY PROFIT, CHANGES NAME
Advanced Therapeutic Products, Inc. Announces First Product Payments From Nicorette Inhaler and Italian Product Launch
Advanced Therapeutic Products, Inc. Reports Increased Revenues From Nicotine Inhaler
ATP Announces Growth in Profits
ATP Announces Profits.
SKM Applied Technology Partners Announces Multiple Acquisitions.
ATP Reports Second Quarter Results and Announces New Chairman.
Tennis: TENNIS CHIEFS SERVE UP A FARCE IN DRUG-TEST ROW.
ATP Oil & Gas Corporation Reports Second Quarter 2004 Results.
'Racist' Oz Davis Cup star banned for calling opponent 'f***ing kaffir'.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters